Kura Oncology, Inc. (KURA)
Latest KURA Insider Trades
About Kura Oncology, Inc. (KURA)
Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.
- SAN DIEGO, CA
- 260
- 2015
- XNAS
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 2 | 200,000 | $2.35M |
| Open-market sale | 3 | 120,761 | $1.28M |
| Grant or award | 7 | 245,000 |
KURA Insider Transactions (Form 4)
3549 Form 4 filings on record, the earliest from Nov 19, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Grant or award | Common Stock |
Recent KURA Form 8-K Filings
5Recent KURA Form 144 Notices of Proposed Sale
3A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| BRIAN POWL | Officer | 4,345 | $51K | View on EDGAR | |
| TERESA BAIR | Officer |
KURA Insider Trading - FAQ
What is the latest insider trade for KURA?
Kura Oncology, Inc. (KURA) had 12 insider filings in the last 90 days, with the most recent on 2026-08-24. The full record for KURA runs to 49 Form 4 filings, the earliest from 2024-11-19. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying KURA stock?
2 insider purchases of KURA were filed in the last 90 days, totaling $2.35M.
How many insiders are selling KURA stock?
3 insider sales of KURA were filed in the last 90 days, totaling $1.28M.
Where can I see KURA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks KURA Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow KURA insider buys?
Create a free InsiderAlpha account and press Watch on this page to add KURA to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Brian T. Powl view on EDGAR
- - Troy Edward Wilson view on EDGAR
- - Teresa Brophy Bair view on EDGAR
- - Troy Edward Wilson view on EDGAR
- - Mollie Leoni view on EDGAR
- - Diane L. Parks view on EDGAR
- - Michael Vasconcelles view on EDGAR
- - Faheem Hasnain view on EDGAR
- - Helen Louise Collins view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where KURA's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track KURA insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.